Press release
Global Pharmaceutical Packaging Market Size, Segments, Outlook, and Revenue Forecast 2022-2028: Ken Research
The Global Pharmaceutical Packaging Market is expected to record a positive CAGR of ~9% during the forecast period (2022-2028) and is expected to reach nearly US$ 180 billion by 2028, owing to several factors including the surging demand for pharmaceutical products to treat various diseases including chronic diseases, digestive disorders, and others, which ultimately boosting the demand for pharmaceutical packaging to protect medicines or drugs from chemical, physical damage, and microbial contamination.For more information, request a free samplehttps://www.kenresearch.com/sample-report.php?Frmdetails=NTk2MDEy
Key Growth Drivers
Growing demand for eco-friendly and sustainable pharmaceutical packaging products and the rising prevalence of chronic diseases increasing the demand for pharma products drive market growth.
The increasing concern related to the harmful impact of packaging on the environment among consumers and manufacturers is surging the demand for eco-friendly and sustainable packaging in the pharmaceutical industry. The growing demand for sustainable packaging is likely to create immense opportunities for the growth of the pharmaceutical packaging market in the forthcoming years.
In April 2022, Amcor plc launched a new sustainable packaging named High Shield laminated, which provides a high barrier and performance to pharmaceutical products. The new product is a recycle-ready and low carbon packaging option that comprises stick pack, sachet, and strip pack packaging and is available in two options, paper-based, and polyolefin-based materials.
The rising prevalence of various diseases including cardiovascular diseases, digestive disorders, infectious diseases, and others increased the demand for pharmaceutical products and their packaging, which is expected to aid the growth of the global pharmaceutical packaging market.
According to World Health Organization (WHO), approximately 17.9 million people die each year due to cardiovascular diseases including rheumatic heart disease, coronary heart disease, cerebrovascular disease, and other conditions.
Shortage of raw materials and counterfeit pharmaceutical products hindering the market growth
The availability of counterfeit pharmaceutical products along with the shortage of raw materials to manufacture pharmaceutical packaging products is the most significant barrier to the growth of the pharmaceutical packaging industry globally. The shortage of basic materials such as paper, plastic, glass, and other raw material has upended the manufacturing process including pharmaceutical packaging. Paper Mills failed to fulfill the demand for paper packaging products due to the shortage of wood pulp.
According to the USA Bureau of Labor Statistics, the cost of pulp and paper increased by over 25% between 2020 and 2021, making it more expensive to procure paper as a raw material for the packaging industry.
During the COVID-19 pandemic, the disrupted supply chain affected the production capacity and supply of pharmaceutical packaging material. In April 2020, the COVID-19 lockdown affected the pharma sector including pharmaceutical packaging due to the shortage of raw material, workforce, and restrictions on transport. To curb the situation, the governmental bodies imposed several regulations on industries, resulting in supply chain disruption.
For More Information on the Research Report, refer to below links: -
https://www.kenresearch.com/business-research/global-pharmaceutical-packaging-market-outlook-2028/
Key Trends by Market Segment:
By Material: Plastics & polymers segment held the largest share of the Global Pharmaceutical Packaging Market in 2021, owing to the various advantages offered by plastic and polymers such as durability, recyclability, flexibility, leakage resistance, lightweight, and others. The demand for various types of plastic including polypropylene (PP), PET, HDPE, PVC, and others is increasing to manufacture caps, lids, trays, plates, blister packages, bottles, bags, and others, which is anticipated to propel the growth of the pharmaceutical packaging market globally.
The surging demand for recyclable, biodegradable, and lightweight materials for pharmaceutical use is encouraging manufacturers to launch new packaging products made from plastic and polymers in the market.
In May 2022, Bormioli Pharma launched Eco Positive Packaging for pharmaceutical products. The packaging includes bio-based, biodegradable, or compostable plastic solutions, recycled glass and plastics, and advanced polymer products. The company aimed to provide sustainable solutions and expand its product portfolio.
By Packaging Type: Primary pharmaceutical packaging segment held the largest share of the Global Pharmaceutical Packaging Market in 2021, owing to the growing demand for packaging products that provides quality assurance, safety during transportation, and prevention from contamination. The primary pharmaceutical packaging includes products such as bottles, tubes, blister packs, and others. It comes in direct contact with the drug or medicines, enveloping it and protecting it from environmental contaminations. In addition, the increasing demand for easy-to-open and convenient packaging options is further expected to augment the growth of the segment in the market.
In August 2022, SEA Vision and Marchesini Group collaborated to launch a new solution for the healthcare industry's primary pack serialized blister and aggregation solutions. The new solution comprised a complete range of technology to inspect, print, and pack serialized blisters. The company aims to offer solutions for pharmaceutical packaging to reduce counterfeiting drugs or medicines in the market.
By Product Type: Bottles segment held the largest share of the Global Pharmaceutical Packaging Market in 2021, due to the growing demand to store liquid drugs, powders, capsules, and others to preserve, protect, and store pharmaceutical products. Moreover, the demand is increasing owing to its durability, easy usage, child resistance, and convenience for the end-users. In addition, increasing government initiatives to promote bottles for pharmaceuticals products as safe packaging, is anticipated to augment the growth of the market.
In March 2021, National Green Tribunal (NGT) declared polyethylene terephthalate (PET) bottles safer for the packaging of pharmaceutical products. Both government, the scientific community, and the pharmaceutical industry endorsed PET bottles and have approved their usage based on scientific facts. PET is considered a strong, safe, clear, lightweight, and completely recyclable material for pharmaceutical packaging.
By Drug Delivery Mode: The oral drugs segment accounted for the majority share of the Global Pharmaceutical Packaging Market in 2021, owing to the surge in storage and protection of oral drugs as the most preferred administration route due to its convenience, high patient compliance, noninvasiveness, and non-requirement of any specific sterile conditions. In addition, the increase in initiatives taken by pharmaceutical manufacturers to develop oral drugs as these are easy to manufacture, cost-effective, and patient-friendly is anticipated to further propel the growth of the segment in the market.
In January 2022, Catalent introduced a new Xpress Pharmaceutics service, which is designed to accelerate the development of oral drugs through Phase 1 clinical studies. The new service allows the company to work alongside clinical research organizations and innovators and also provides clinical trial material that can ease the process of clinical studies.
By End-User: Pharma manufacturing segment accounted for the largest share in 2021 of the Global Pharmaceutical Packaging Market attributed to increasing demand for medicines or drugs along with the rising population and increasing prevalence of various diseases namely cardiovascular disease, physiological, hereditary, infectious, and other diseases. In addition, an increase in the geriatric population requires additional medical assistance, thereby boosting pharmaceutical manufacturing activities. The above-mentioned factors are expected to augment the growth of the global pharmaceutical packaging market.
In January 2020, West Pharmaceutical Services, Inc. introduced a new packaging component named AccelTRA for packaging injectable drugs for generic drug manufacturers in India. The new product launch aimed to enhance the company's product portfolio and to offer high quality, speedy packaging, and simple products to pharma manufacturers.
By Geography: North America accounted for the largest share in 2021 of the Global Pharmaceutical Packaging Market due to the presence of many pharmaceutical packaging manufacturers in the region along with the strong production capacity for pharmaceutical products and packaging. In addition, the rising adoption of smart, advanced, and sustainable packaging for pharmaceutical products is anticipated to propel the growth of the region in the market.
In March 2020, Berry Global, Inc. launched a new oval tube for packaging pharmaceuticals and other products. The oval tube is formed, extruded, and decorated at the USA manufacturing facility. The oval tube has a unique shape and helps manufacturers and brands to differentiate their products from other brands' products.
Asia-Pacific is the fastest growing region in the Global Pharmaceutical Packaging Market owing to the growing demand for pharmaceutical products and their packaging. Moreover, the supportive regulations laid by the governmental bodies related to the safety of drugs are further expected to boost the growth of the region in the Pharmaceutical Packaging Market.
For more information, request a free samplehttps://www.kenresearch.com/sample-report.php?Frmdetails=NTk2MDEy
Competitive Landscape
The pharmaceutical packaging market is highly competitive with ~300 players that include globally diversified players, regional players as well as a large number of country-niche players having their niche in pharmaceutical packaging.
Regional players control over 45% of the market share, while the global players hold the second largest share. Some of the major players in the market include Amcor plc, BD, AptarGroup, Inc., Gerresheimer AG, West Pharmaceutical Services, Inc., WestRock Company, CCL Industries, Berry Global, Inc., Nipro Europe Group Companies, and Mondi plc among others.
The leading global pharmaceutical packaging companies such as Amcor plc, West Pharmaceutical Services, Inc., and AptarGroup, Inc. are highly focused on research and development for creating innovative sustainable pharmaceutical packaging products or solutions.
Recent Developments Related to Major Players
In November 2021, Gerresheimer AG launched a new drug delivery device named SensAIR for drugs with high viscosity. The new primary packaging is launched to deliver newly developed biologics and other medical and diagnostic products.
In May 2021, Nipro Europe Group Companies acquired Piramida, a Croatian glass pharmaceutical packaging manufacturer. The acquisition helped the company in catering to the growing demand for glass packaging in the Central European market and aimed to expand its business globally.
Conclusion
The Global Pharmaceutical Packaging Market is forecasted to continue a moderate growth, primarily driven by the rising demand for pharmaceutical products coupled with an increase in the introduction of new medicines, biologics products, and other drugs to improve patient health and their quality of life. In addition, the growing demand for reliable and innovative packaging for pharmaceutical products to prevent, preserve, and protect them from any chemical, physical, or microbial damage is anticipated to propel the growth of the market globally Though the market is highly competitive with over 300 participants, few regional players control the dominant market share and global players also hold a significant market share.
Note: This is an upcoming/planned report, so the figures quoted here for a market size estimate, forecast, growth, segment share, and competitive landscape are based on initial findings and might vary slightly in the actual report. Also, any required customizations can be covered to the best feasible extent for Pre-booking clients and report delivered within a maximum of two working weeks.
Ken Research has recently published report titled, Global Pharmaceutical Packaging Market Size, Segments, Outlook, and Revenue Forecast 2022-2028. In addition, the report also covers market size and forecasts for the four region's pharmaceutical packaging market. The revenue used to size and forecast the market for each segment is US$ billion.
Market Taxonomy
By Material
Plastics & Polymers
Paper & Paperboard
Glass
Aluminum Foil
Others
By Packaging Type
Tertiary Pharmaceutical Packaging
Secondary Pharmaceutical Packaging
Primary Pharmaceutical Packaging
By Product Type
Bottles
Caps & Closures
Pre-Fillable Inhalers
Pre-Fillable Syringes
Vials & Ampoules
Blister Packs
Bags & Pouches
Jars & Canisters
Cartridges
Others
By Drug Delivery Mode
Oral Drugs
Injectables
Topical
Ocular/ Ophthalmic
Nasal
Pulmonary
Transdermal
IV Drugs
Others
By End-User
Pharma Manufacturing
Contract Packaging
Retail Pharmacy
Institutional Pharmacy
Others
By Geography
North America
US
Canada
Mexico
Europe
Germany
UK
France
Spain
Italy
Asia-Pacific
China
Japan
South Korea
India
Indonesia
Australia
LAMEA
Latin America
Middle East
Africa
Key Companies
Amcor plc
Becton D
AptarGroup, Inc.
Gerresheimer AG
West Pharmaceutical Services, Inc.
WestRock Company
CCL Industries
Berry Global, Inc.
Nipro Europe Group Companies
Mondi plc
Ken Research Pvt. Ltd.,
Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49 Gurgaon, Haryana - 122001, India
Ken Research is a Market Research and Consulting Firm, based out of India, Indonesia and UAE. Since 2011, we have been assisting clients globally with our Syndicate and Bespoke Market Research and Advisory Services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Pharmaceutical Packaging Market Size, Segments, Outlook, and Revenue Forecast 2022-2028: Ken Research here
News-ID: 2844537 • Views: …
More Releases from Ken Research Pvt .Ltd

India Shrimp and Red Chilles Market - Ken Research Stated the Sector Valued at ~ …
Comprehensive market analysis maps export expansion, cold-chain investments, and value-added opportunities across India's aquaculture and spices ecosystem
Delhi, India - September 12, 2025 - Ken Research released its strategic market analysis titled "India Shrimp and Red Chilles Market Outlook to 2030," revealing that India's combined shrimp and red chillies market valued at USD 13000 billion, on the most recent market data for shrimp. The comprehensive analysis details how export-oriented aquaculture and…

India TMS Market - Ken Research Stated the Sector Valued at ~INR 4 Crore with St …
Comprehensive market analysis maps defense and aerospace growth trajectory, investment opportunities, and strategic imperatives for industry leaders in India's evolving TMS ecosystem
Delhi, India - September 12, 2025 - Ken Research released its strategic market analysis titled "India TMS Market Outlook to 2029," revealing that India's Test, Measurement & Simulation (TMS) market is valued at ~INR 4 crore and is projected to grow steadily through 2029. The comprehensive analysis details how…

KSA Debt Collection Market Reached ~USD 800 million, Stated Ken Research
Comprehensive market analysis maps regulatory reforms, digital collections acceleration, and strategic imperatives across Saudi Arabia's maturing credit ecosystem
Delhi, India - September 12, 2025 - Ken Research released its strategic market analysis titled "KSA Debt Collection Market Outlook to 2030," revealing that Saudi Arabia's debt collection market valued at ~USD 800 million, -is projected to surpass USD xx billion by 2030. The comprehensive analysis details how placements and recoveries are expected…

KSA Luxury Car Market - Ken Research Stated the Sector Valued at ~USD 4.0 billio …
Comprehensive market analysis maps premium demand trajectory, investment opportunities, and strategic imperatives for industry leaders in the Kingdom's evolving luxury mobility ecosystem
Delhi, India - September 12, 2025 - Ken Research released its strategic market analysis titled "KSA Luxury Car Market Outlook to 2030," revealing that Saudi Arabia's luxury car market is currently valued at USD 4.0 billion and is projected to surpass USD xx billion by 2030. The comprehensive analysis…
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…